This page defines the modelling rules and description templates for Phase 1 only of the Canadian Medicines Terminology (CMT) project. Phase-specific content will be added as the project progresses.
The representation of a medicinal product supplied by a single organization (supplier) in Canada under a single product name, and which contains the same set of precise active ingredients, stated basis of strength substance with strength, and dose form.
Attributes and Concepts
The TCD uses the following defining attributes:
Attribute | Alias | Group | Card | G Card | D/O | Range |
373873005 |Count of base of active ingredient| | BCount | NO | 1..1 | 0..0 | DATA | Integer >#0.. |
762949000 |Has precise active ingredient | PAI | YES (1,2) | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
732943007 |Has basis of strength substance| | BOSS | YES (1,2) | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
411116001|Has manufactured dose form| | MDF | NO | 0..1 | 0..0 | OBJECT | < 736542009 |Pharmaceutical dose form| |
763032000 |Has unit of presentation| | UOP | NO | 0..1 | 0..0 | OBJECT | < 732935002 |Unit of presentation| |
1142135004 |Has presentation strength numerator value| | PSNV | YES (1) | 0..* | 0..1 | DATA | Decimal >#0.. |
732945000 |Has presentation strength numerator unit| | PSNU | YES (1) | 0..* | 0..1 | OBJECT | < 767524001 |Unit of measure| |
1142136003 |Has presentation strength denominator value| | PSDV | YES (1) | 0..* | 0..1 | DATA | Decimal >#0.. |
732947008 |Has presentation strength denominator unit| | PSDU | YES (1) | 0..* | 0..1 | OBJECT | < 767524001 |Unit of measure| |
774167006 |Product name| | ProdName | NO | 0..1 | 0..0 | OBJECT | < 774167006 |Product name| |
774164004 |Supplier| | Supplier | NO | 0..1 | 0..0 | OBJECT | < 774164004 |Supplier| |
Descriptions generation
TCD generation of the en-CA Fully Specified Name (FSN)
Format
[[ + @ProdName]]1 [“ [[ + @BOSS]] [“ (as ” [[ + @PAI]] “)”]2“ ” [[ + @PSNV]] “ ” [[ + @PSNU]]“/” [[ + @PSDV]] “ each” [[ + @MDF]] “] (” [[ + @Supplier]] 3 “) (real clinical drug)” 4
TCD generation of the en-CA Preferred Term (PT)
Format
[[ + @ProdName]]1 “ [“ [[ + @BOSS]] ( “(“[[ + @PAI]]2 “)”) “ ” [[ + @PSNV]] “ ” [[ + @PSNU]] “ ” [[ + @MDF]](” [[ + @Supplier]]3 “)” 5
Rules for English descriptions
1: ProdName is always fully capitalized
2: PAI is used here when BOSS <> PAI
3: Supplier is always fully capitalized
4: For all attribute values, use the en-CA FSN with no semantic tag
5: For all attribute values, use the en-CA PT
TCD generation of the fr-CA Fully Specified Name (FSN)
Format
[[ + @ProdName]]1 “ [“ [[ + @BOSS]] [“ (” [[ + @PAI]] “)”]2“ ” [[ + @PSNV]] “ ” [[ + @PSNU]] “/ ” [[ + @PSDV]] “ chaque” [[ + @MDF]] ] “ ] (” [[ + @Supplier]] 3 “) (médicament clinique commercial)” 4
TCD generation of the fr-CA Preferred Term (PT)
Format
[[ + @ProdName]]1 “ [“ [[ + @BOSS]]2 ( “(“[[ + @PAI]] “)”) “ ” [[ + @PSNV]] “ ” [[ + @PSNU]] “” [[ + @MDF]] “] (” [[ + @Supplier]]3“)” 5
Rules for French descriptions
1: ProdName is always fully capitalized
2: PAI is used here when BOSS <> PAI
3: Supplier is always fully capitalized
4: For all attribute values, use the fr-CA FSN with no semantic tag
5: For all attribute values, use the fr-CA PT